④HER-MES試験(2) 片頭痛症例について標準治療薬(topiramate:TPM)に対するerenumabの忍容性と有効性を評価した最初のhead to head第4相試験のPost hoc解析 erenumabはTPM投与群に対して、早期に50%以上の月間片頭痛日数(MMD)減少を達成し、有意に優れた効果 https://t.co/M2lyukRUhQ
1,313 followers
948 followers
RT @UweReuter3: https://t.co/79D5NGUAhk Erenumab versus topiramate in migraine prophylaxis: efficacy analysis in patients who tolerate top…
297 followers
RT @UweReuter3: https://t.co/79D5NGUAhk Erenumab versus topiramate in migraine prophylaxis: efficacy analysis in patients who tolerate top…
860 followers
RT @UweReuter3: https://t.co/79D5NGUAhk Erenumab versus topiramate in migraine prophylaxis: efficacy analysis in patients who tolerate top…